<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Laurence Delbrassinne</style></author><author><style face="normal" font="default" size="100%">Valeska Laisnez</style></author><author><style face="normal" font="default" size="100%">Mieke De Weweire</style></author><author><style face="normal" font="default" size="100%">Jean Vanderpas</style></author><author><style face="normal" font="default" size="100%">Katelijne Dierick</style></author><author><style face="normal" font="default" size="100%">Sarah Denayer</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Very Long Persistence of Botulinum Toxin B in a Patient’s Serum</style></title><secondary-title><style face="normal" font="default" size="100%">The Open Infectious Diseases Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Bioassay</style></keyword><keyword><style  face="normal" font="default" size="100%">BoNT</style></keyword><keyword><style  face="normal" font="default" size="100%">Botulinum neurotoxins</style></keyword><keyword><style  face="normal" font="default" size="100%">Botulism</style></keyword><keyword><style  face="normal" font="default" size="100%">Clostridium botulinum</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunocompromised</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2018</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">191</style></number><volume><style face="normal" font="default" size="100%">10</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Background:&lt;/p&gt;

&lt;p&gt;Botulinum toxins (BoNT) type A, B, E, F may induce a serious neuroparalytic illness in humans. Botulism can be transmitted via&lt;/p&gt;

&lt;p&gt;three routes: foodborne, wound and intestinal (in situ toxemia generally observed in infants and/or in immunocompromised adults)&lt;/p&gt;

&lt;p&gt;botulism.&lt;/p&gt;

&lt;p&gt;Case Report:&lt;/p&gt;

&lt;p&gt;A case of human botulism type B due to the consumption of an imported dried ham is reported. Laboratory results confirmed the&lt;/p&gt;

&lt;p&gt;diagnosis using the mouse bioassay and the qPCR method. Botulinum toxin was still detected in the serum up to 29 days after food&lt;/p&gt;

&lt;p&gt;consumption while it was not detected anymore in the faeces.&lt;/p&gt;

&lt;p&gt;Conclusion:&lt;/p&gt;

&lt;p&gt;The described case highlights i) prolonged presence of BoNT B in the serum and ii) the risks related to the preparation of artisanal&lt;/p&gt;

&lt;p&gt;products as well as the importance of an efficient communication to citizens regarding preservation methods of household products.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><section><style face="normal" font="default" size="100%">187</style></section></record></records></xml>